Mynster Kronborg, Thit http://orcid.org/0000-0001-6344-8564
Webel, Henry http://orcid.org/0000-0001-8833-7617
O’Connell, Malene Barfod http://orcid.org/0000-0001-7226-8821
Danielsen, Karen Vagner http://orcid.org/0000-0001-7194-4541
Hobolth, Lise http://orcid.org/0000-0002-7607-3551
Møller, Søren http://orcid.org/0000-0001-9684-7764
Jensen, Rasmus Tanderup http://orcid.org/0000-0002-4241-3394
Bendtsen, Flemming http://orcid.org/0000-0002-8419-2104
Hansen, Torben http://orcid.org/0000-0001-8748-3831
Rasmussen, Simon http://orcid.org/0000-0001-6323-9041
Juel, Helene Bæk http://orcid.org/0000-0002-5763-8545
Kimer, Nina http://orcid.org/0000-0002-4807-1575
Clinical trials referenced in this document:
Documents that mention this clinical trial
Markers of inflammation predict survival in newly diagnosed cirrhosis: a prospective registry study
https://doi.org/10.1038/s41598-023-47384-2
Documents that mention this clinical trial
Markers of inflammation predict survival in newly diagnosed cirrhosis: a prospective registry study
https://doi.org/10.1038/s41598-023-47384-2
Funding for this research was provided by:
Novo Nordisk Fonden (NNF19SA0035440, NNF18CC0034900)
Beckett-Fonden (20-2-6102)
Novo Nordisk Foundation Center for Basic Metabolic Research (SABridge.ku.dk)
Article History
Received: 5 June 2023
Accepted: 13 November 2023
First Online: 16 November 2023
Competing interests
: The authors declare no competing interests.